The effects of inhibition of protein glycosylation on the aggregation of Dictyostelium discoideum.
At concentrations greater than 10 micrograms ml-1 tunicamycin inhibited the incorporation of [3H]mannose into glycoproteins during the early phase of development in Dictyostelium discoideum, however, total protein synthesis was unaffected. Tunicamycin also interfered with the normal process of aggregation. In its presence small aggregates were observed at the time of normal aggregation, but amoebae failed to aggregate completely and subsequent development was inhibited. Inhibition of normal aggregation by tunicamycin was found to be reversible. The appearance of cell-associated and secreted cyclic AMP phosphodiesterase and cell-surface contact sites A was prevented by tunicamycin but cell surface cyclic AMP receptor activity developed normally in its presence. Tunicamycin also prevented amoebae from acquiring the ability to chemotact toward cyclic AMP. Addition of exogenous cyclic AMP phosphodiesterase restored the ability of amoebae to chemotact toward cyclic AMP in the presence of tunicamycin. Our data suggest that the primary block in aggregation caused by tunicamycin results from the inhibition of expression of active cyclic AMP phosphodiesterase.
D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000378:metabolism; D002633:Chemotaxis / Q000187:drug effects; D000242:Cyclic AMP / Q000378:metabolism; D004023:Dictyostelium / Q000187:drug effects / Q000254:growth & development* / Q000378:metabolism; D005656:Fungal Proteins / Q000378:metabolism*; D005944:Glucosamine / Q000031:analogs & derivatives*; D006023:Glycoproteins / Q000096:biosynthesis; D007930:Leucine / Q000378:metabolism; D008358:Mannose / Q000378:metabolism; D009068:Movement; D014415:Tunicamycin / Q000494:pharmacology*
D005656:Fungal Proteins; D006023:Glycoproteins; D014415:Tunicamycin; D000242:Cyclic AMP; D015105:3',5'-Cyclic-AMP Phosphodiesterases; D007930:Leucine; D005944:Glucosamine; D008358:Mannose